Early AGEing and metabolic diseases: is perinatal exposure to glycotoxins programming for adult-life metabolic syndrome?

Nutr Rev. 2021 Jan 1;79(1):13-24. doi: 10.1093/nutrit/nuaa074.

Abstract

Perinatal early nutritional disorders are critical for the developmental origins of health and disease. Glycotoxins, or advanced glycation end-products, and their precursors such as the methylglyoxal, which are formed endogenously and commonly found in processed foods and infant formulas, may be associated with acute and long-term metabolic disorders. Besides general aspects of glycotoxins, such as their endogenous production, exogenous sources, and their role in the development of metabolic syndrome, we discuss in this review the sources of perinatal exposure to glycotoxins and their involvement in metabolic programming mechanisms. The role of perinatal glycotoxin exposure in the onset of insulin resistance, central nervous system development, cardiovascular diseases, and early aging also are discussed, as are possible interventions that may prevent or reduce such effects.

Keywords: advanced glycation end products (AGEs); glycotoxins; metabolic programming; metabolic syndrome; methylglyoxal.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aging*
  • Animals
  • Female
  • Fetus
  • Glycation End Products, Advanced / metabolism
  • Glycation End Products, Advanced / toxicity*
  • Humans
  • Infant
  • Infant, Newborn
  • Insulin Resistance
  • Metabolic Syndrome / etiology*
  • Metabolic Syndrome / metabolism
  • Metabolic Syndrome / physiopathology
  • Oxidative Stress
  • Pregnancy
  • Prenatal Exposure Delayed Effects
  • Pyruvaldehyde / toxicity

Substances

  • Glycation End Products, Advanced
  • Pyruvaldehyde